Study On Parameter Optimization of 3D Bioprinting of Hybrid Bio-Inks

Abstract Used mainly for manufacturing operative tissue structures to replace damaged ones, Three-dimensional (3D) Bioprinting is a burgeoning area of medical science with enormous potential. Since the technology is still relatively new, 3D bioprinting heavily relies on the trial-and-error approach for advancement, but the general process currently involves a mixture of various biomaterials in hydrogel form. The quality of the results is affected significantly by the parameters by which the print is made. Even the most seemingly minute details can drastically change the outcome of the print, including temperature, print time, the speed of the occurring print and nozzle diameter, dispensing pressure, and more. The biomaterial used is also of the utmost importance. Based on current results, an ideal biomaterial should include the same or similar chemical, biological, mechanical, and practical properties of the target end structure. It is critical to ascertain the closest parameters available to ensure a quality end resulting print. The proposed studies' goal is to determine and streamline process parameters to the nearest possible degree to optimize the bioprinting process of hybrid bioinks. Using material made from unchanged alginate, alginate with gelatin, and combined amino acids and derivatives with diphenylalanine, the medical properties of each biomaterial were examined, as well as their flow behavior, allowing a certain level of predictability on printing parameters. Printing parameters, as described, are the parameters by which we can predict how well a target structure can be accurately constructed using various bio-inks. Ultimately, the results have indicated that printing parameters primarily hinges on the composition of the hydrogels used and the pressure by which it was distributed. This study also presented a detailed frame of reference to assess amino acids and derivatives with diphenylalanine systematically, which can also be used in other areas of 3D bioprinting.